The implementation of new policy frameworks, India’s pharmaceutical contract manufacturing industry is emerging as a key player on the global stage,” said Sameer Hiremath, Vice Chairman and Managing Director, Hikal Ltd
According to Saransh Chaudhary, president of Global Critical Care at Venus Remedies and CEO of the Venus Medicine Research Centre, environmental restrictions are desperately needed because antibiotic levels in urban and industrial wastewater around
Xspray Pharma signed a deal with Handa Therapeutics that will give it up to double-digit royalties on Handa's net profits, marking the company's first out-licensing arrangement from its patent portfolio
STEER World, a global leader in advanced materials platform technology, has successfully demonstrated a 200 kg/hour continuous run of Metformin granules using its patented INTEGRAAL Continuous Granulation System
SCHOTT, the world leader in specialty glass production, has expanded its manufacturing plant in Jambusar, Gujarat, introducing Syringe and cartridge glass tubing made in India. This transforms SCHOTT into the biggest provider of syringe and cartridge
.jpeg)
The global Specialty Pharmaceuticals Market is at the vanguard of healthcare innovation, stirred by cutting-edge treatments, quick development, and evolving industry trends. The global market size increased by USD 280.7 billion in 2024 and is expecte
The US market expansion through the introduction of new products in the gastrointestinal, pain management, and digestive health division’s propelled the company's reported revenue of Rs. 620 crore, up 5% year over year
Indoco Remedies Ltd. has obtained final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application
US pharmaceutical giant Eli Lilly stepped up competition with rival Danish drugmaker Novo Nordisk on Wednesday by introducing its popular diabetes medication Mounjaro in the Indian market. KwikPen is a single patient use prefilled pen intended for on
Zydus Lifesciences, a leading Indian pharmaceutical, is preparing to launch semaglutide variants, the active ingredient in antidiabetic and weight-loss drugs, as the patent nears expiration in 2026. The firm is expected to invest over ?100...
.jpg)
.jpg)
, CDSCO.jpg)